Drug profile · INN
deflazacort
DEFLAZACORT
deflazacort (DEFLAZACORT) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — deflazacort
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 7
- Data quality
- 0.89
Quick answer
deflazacort (DEFLAZACORT) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is deflazacort?
deflazacort (DEFLAZACORT) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for deflazacort?
DEFLAZACORT is a marketed brand name for deflazacort. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of deflazacort?
deflazacort has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.